CURAVIS
Board
2 directors, no change since 2023Sole manager
appointed by deed of 07-10-2019
listed in the 2025 annual accounts, filed on 26-08-2026
Director
appointed by deed of 12-05-2023
term without a fixed end
earlier manager, until 12-05-2023
listed in the 2025 annual accounts, filed on 26-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 13. Vertegenwoordigingsbevoegdheid Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als…”deed of 12-05-2023
Mandates through the years
2 names, the dashed line is todaySole manager
Director
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Sole manager, appointed by deed of 07-10-2019, still in office
-
- Director, appointed by deed of 12-05-2023, still in office
- Manager, until 12-05-2023
Control
Shareholders
,
This company
CURAVIS
Equity €143,295
Profit €19,444 in 2025
Capital
- Contribution
- €3,000
- Shares
- 30
- Contribution per share
- €100
- Equity per share
- €4,777 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 12-05-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 19:00
Shareholders
Stated in the deed
deed of 12-05-2023 ↗
- 29 shares
- 1 share
At incorporation
deed of 07-10-2019 ↗
- gecommanditeerde vennoot · €2,900 in cash
Capital transactions
Capital over time
- 12-05-2023 Converted to unavailable equity
- 07-10-2019 Incorporation · €3,000 · 30 shares